ArticleOpen forum infectious diseases2025

Impact of Rituximab on COVID-19 in Immunocompromised Patients: A Nationwide Cohort Study in Korea.

Chan Mi Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.